Summary
Previous studies have shown that synthesis of a 24,000 molecular weight (24k) protein (7) and the mRNA activity coding for a 24k protein (8) are selectively stimulated by estradiol in MCF-7 human breast cancer cells. Utilizing a double-label electrophoresis technique to measure the relative rates of specific protein synthesis, the present study relates further characterization of this estrogen response. The 24k protein was found to be stimulated by estradiol provided cells were preincubated with antiestrogen. Under these conditions, antiestrogens inhibit cell growth and addition of estradiol reverses growth inhibition (estrogen growth ‘rescue’). As a control experiment, specific protein synthesis was measured in another growth rescue model produced by withdrawing serum from the medium to inhibit growth and then stimulating cells by readdition of serum (serum growth ‘rescue’). This failed to stimulate synthesis of a 24k protein, implying that the effect observed following estrogen ‘rescue’ was not a non-specific result of growth stimulation. Increased 24k synthesis was found to be both time and estrogen-dose dependent and required specifically those steroid hormones which interact with the estrogen receptor. Moreover, the dose response curve for 24k stimulation paralleled closely the dose response for estrogen stimulation of nuclear estrogen receptor processing, an event correlated with another estrogenic response in MCF-7 cells, induction of progesterone receptor. These findings suggest that estradiol itself directly stimulates synthesis of the 24k protein through interaction with the estrogen receptor system. Further separation of double-label cytosols by two-dimensional electrophoresis resolved the 24k protein into two isoelectric species with pI's in the range of 6.7–6.9 and 6.4–6.7, the latter being the most abundant or rapidly labeling protein. Based on the percentage of total cytosol incorporation contained in individual two-dimensional gel spots, the major species of 24k represented in the fully stimulated cell (3H-counts) about 1.6% of newly synthesized protein. It also represented about 0.7% of newly synthesized protein in the unstimulated (14C-counts) cell, which indicates that 24k is synthesized constitutively. Because of its relative abundance, the 24k protein may be a suitable end product for investigating the mechanisms of estrogen action in human breast cancer.
Abbreviations
- ER:
-
estrogen receptor
- DHT:
-
dihydrotestosterone
- Hepes:
-
N1-2-hydroxyethylpiperazine-N1-ethane sulfonic acid
- MEM:
-
Eagle's minimum essential medium
- TCA:
-
trichloroacetic acid
- SDS:
-
sodium dodecylsulfate; nafoxidine, (1-(2-[p-(3,4-dihydro-6-methoxy-2phenyl-1-naphthyl) Phenoxy]ethyl) pyrrolidine hydrochloride; Upjohn); tamoxifen, (1-p-β-dimethylaminoethyoxyphenyl-trans-1,2-diphenylbut-1-ene; ICI-46474); CI-628,1-[2-[p[α-(p-methoxyphenyl)-β-nitrostyryl]-phenoxy]ethyl]pyrrolidine monohydrate monocitrate
References
Edwards DP, Chamness GC, McGuire WL: Estrogen and progesterone receptor proteins in human breast cancer. Biochem Biophys Acta 560: 457–486, 1979
Engel LW, Young NA: Human breast carcinoma cells in continuous culture: a review. Cancer Res 38: 4327–4339, 1978
Horwitz KB, Zava DT, Arulasanam KT, Jensen EM, McGuire WL: Steroid receptor analysis of nine human breast cancer cell lines. Cancer Res 38: 2434–2437, 1978
Horwitz KB, McGuire WL: Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 253: 2223–2228, 1978
Westley B, Rochefort H: A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20: 353–362, 1980
Butler WB, Kirkland WL, Jorgensen TL: Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7). Biochem Biophys Res Commun 90: 1328–1334, 1979
Edwards DP, Adams DJ, Savage N, McGuire WL: Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem Biophys Res Commun 93: 804–812, 1980
Adams DJ, Edwards DP, McGuire WL: Estrogen regulation of specific messenger RNA's in human breast cancer cells. Biochem Biophys Res Commun 97: 1354–1361, 1980
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951
Laemmli UK: Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227: 680–685, 1970
Wykoff M, Rodbard D, Chrambach A: Polyacrylamide gel electrophoresis in sodium dodecyl sulfate-containing buffers using multibasic buffer solutions. Properties of the stack, valid Rf-measurements and optimized procedure. Anal Biochem 78: 459–482, 1977
O'Farrell PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007–4021, 1975
Horwitz KB, McGuire WL: Nuclear mechanisms of estrogen action. J Biol Chem 253: 8185–8191, 1978
Katzenellenbogen BS, Gorski J: Estrogen action in vitro: induction of the synthesis of a specific uterine protein. J Biol Chem 247: 1299–1305, 1972
Edwards DP, Murthy SR, McGuire WL: Estrogen and antiestrogen effects on DNA polymerase activity in human breast cancer. Cancer Res 40: 197–213, 1980
Zava DT, McGuire WL: Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology 103: 624–631, 1978
Haagensen DE, Mazoujlan G, Dilley WG, Pedersen CE, Kister SJ, Wells SA: Breast gross cystic disease fluid analysis I. Isolation and radioimmunoassay for a major protein component. J Nat Can Inst 62: 239–247, 1979
Jozan S, Mowe C, Gillois M, Bayard F: Effects of estrone on cell proliferation of a human breast cancer (MCF-7) in long-term tissue culture. J Steroid Biochem 10: 341–342, 1979
Shafie SM: Estrogen and the growth of breast cancer: new evidence suggests indirect action. Science 209: 701–702, 1980
Zava DT, Chamness GC, Horwitz KB, McGuire WL: Human breast cancer: biologically active estrogen receptor in the absence of estrogens. Science 196: 663–664, 1977
Lippman M, Bolan G, Huff K: The effects of estrogen and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601, 1976
Vignon FV, Terqui M, Westley B, Ducoq D, Rochefort H: Effects of plasma estrogen sulfate in mammary cancer cells. Endocrinology 106: 1079–1087, 1980
Strobl JS, Lippman ME: Prolonged retention of estradiol by human breast cancer cells in tissue culture. Cancer Res 39: 3319–3327, 1979
Horwitz KB, Aiginger P, Kutten F, McGuire WL: Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in human breast cancer cells. Endocrinology 108: 1703–1709, 1981
Barnes D, Sato G: Growth of a human mammary tumor cell line in a serum-free medium. Nature 281: 388–389, 1979
Manak R, Wertz N, Slabauch M, Denai H, Wang J-T, Gorski J: Purification and characterization of the estrogeninduced protein (IP) of the rat uterus. Mol Cell Endocrinol 17: 119–132, 1980
Skipper JK, Eakle D, Hamilton TH: Modulation by estrogen of synthesis of specific uterine proteins. Cell 22: 69–78, 1980
Vedeckis WV, Schraeder WT, O'Malley BW: Progesterone binding components of chick oviduct: analysis of receptor structure by limited proteolysis. Biochemistry 19: 343–349, 1980
Author information
Authors and Affiliations
Additional information
Address for reprints: William L. McGuir, M.D., Department of Medicine, University of Texas Health Science Center 7703 Floyd Curl Drive. San Antonio, TX 78284.
Rights and permissions
About this article
Cite this article
Edwards, D.P., Adams, D.J. & McGuire, W.L. Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7). Breast Cancer Res Tr 1, 209–223 (1981). https://doi.org/10.1007/BF01806261
Issue Date:
DOI: https://doi.org/10.1007/BF01806261